NYSEMKT:PHGE

BiomX (PHGE) Stock Forecast, Price & News

$0.33

-0.01 (-2.94%)

(As of 09/29/2023 ET)

Compare

Today's Range: $0.33
▼
$0.36
50-Day Range: $0.32
▼
$0.43
52-Week Range: N/A

Volume: 12,810 shs
Average Volume: 28,619 shs
Market Capitalization: $15.17 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.50

BiomX MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 1,263.6% Upside
$4.50 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.44) to ($0.36) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
BiomX has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $4.50, BiomX has a forecasted upside of 1,263.6% from its current price of $0.33.
Amount of Analyst Coverage
BiomX has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for PHGE.

0.0

Dividend Strength

Dividend Yield
BiomX does not currently pay a dividend.
Dividend Growth
BiomX does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PHGE.

0.6

News and Social Media Coverage

Search Interest
2 people have searched for PHGE on MarketBeat in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BiomX insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.21% of the stock of BiomX is held by insiders.
Percentage Held by Institutions
Only 36.67% of the stock of BiomX is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for BiomX are expected to grow in the coming year, from ($0.44) to ($0.36) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of BiomX is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of BiomX is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
BiomX has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About BiomX (NYSEMKT:PHGE) Stock

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

PHGE Price History

30 days | 90 days | 365 days | Advanced Chart

PHGE Stock News Headlines

August 9, 2023 | msn.com

HC Wainwright & Co. Reiterates BiomX (PHGE) Buy Recommendation

August 9, 2023 | msn.com

BiomX GAAP EPS of -$0.12 beats by $0.02

September 30, 2023 | Chaikin Analytics (Ad)

His system isolated NVIDIA - Here's His Next Buy.

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

July 19, 2023 | uk.finance.yahoo.com

PHGE - BiomX Inc.

June 2, 2023 | finance.yahoo.com

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of BiomX Inc. (PHGE.WS)

May 31, 2023 | finance.yahoo.com

BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)

May 16, 2023 | msn.com

HC Wainwright & Co. Maintains BiomX (PHGE) Buy Recommendation

May 12, 2023 | finance.yahoo.com

BiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directors

September 30, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

May 12, 2023 | msn.com

Why Is BiomX (PHGE) Stock Up 10% Today?

May 8, 2023 | finance.yahoo.com

BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023

April 27, 2023 | ca.finance.yahoo.com

BiomX Inc. (PHGE) Stock Historical Prices & Data - Yahoo Finance

April 19, 2023 | ca.finance.yahoo.com

BiomX Inc. (PHGE-WT)

April 9, 2023 | finance.yahoo.com

BiomX Inc. (AMEX:PHGE) Q4 2022 Earnings Call Transcript

April 1, 2023 | benzinga.com

BiomX Stock (AMEX:PHGE), Dividends

March 29, 2023 | finance.yahoo.com

BiomX Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

February 22, 2023 | finance.yahoo.com

BiomX Announces Positive Results from Part 1 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

February 22, 2023 | finance.yahoo.com

BiomX Announces $7.5 Million Private Placement

November 1, 2022 | msn.com

Wall Street Set to Open Higher Ahead of Manufacturing PMI, Fed Meeting

October 5, 2022 | theglobeandmail.com

BiomX: Top 10 Undervalued Healthcare Stocks on ASE (PHGE)

September 1, 2022 | investing.com

PHGE_u Technical Analysis

August 11, 2022 | seekingalpha.com

BiomX Inc. (PHGE) CEO Jonathan Solomon on Q2 2022 Results - Earnings Call Transcript

August 7, 2022 | finance.yahoo.com

BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022

June 28, 2022 | seekingalpha.com

BiomX stock rises on team up with Boehringer inflammatory bowel disease biomarkers

May 11, 2022 | seekingalpha.com

BiomX Inc. (PHGE) CEO Jonathan Solomon on Q1 2022 Results - Earnings Call Transcript

May 11, 2022 | finance.yahoo.com

BiomX Reports First Quarter 2022 Financial Results and Provides Business Update

May 5, 2022 | finance.yahoo.com

BiomX to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 11, 2022

See More Headlines

Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

PHGE Company Calendar

Last Earnings: 5/15/2023
Today: 9/29/2023
Next Earnings (Estimated): 11/07/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEMKT
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSEMKT:PHGE
CUSIP: N/A
CIK: 1739174
Web: www.biomx.com
Phone: 972 7 23942377
Fax: N/A
Employees: 54
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $4.50
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $2.00
Forecasted Upside/Downside: +1,263.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.75)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-28,320,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -127.82%
Return on Assets: -56.50%

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 2.84
Quick Ratio: 2.84

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.70 per share
Price / Book: 0.47

Miscellaneous

Outstanding Shares: 45,980,000
Free Float: 44,044,000
Market Cap: $15.17 million
Optionable: Not Optionable
Beta: 1.31

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Jonathan Eitan Solomon MBA (Age 46)
CEO & Director
Comp: $528.57k

Ms. Marina Wolfson CPA (Age 39)
CFO & Sec.
Comp: $279.42k

Dr. Merav Bassan Ph.D. (Age 57)
Chief Devel. Officer
Comp: $356.59k

Prof. Rotem Sorek Ph.D.
Scientific Founder

Dr. Eran Elinav M.D.
Ph.D., Scientific Founder

Dr. Timothy K. Lu M.D. (Age 42)
Ph.D., Scientific Founder

Ms. Inbal Benjamini-Elran
C.H.R.O

Mr. Assaf Oron (Age 49)
Chief Bus. Officer

Dr. Inbar Gahali-Sass
VP of Platform R&D

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PHGE Stock - Frequently Asked Questions

Should I buy or sell BiomX stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BiomX in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PHGE shares.
View PHGE analyst ratings or view top-rated stocks.
What is BiomX's stock price forecast for 2023?: 3 brokers have issued 12-month price objectives for BiomX's shares. Their PHGE share price forecasts range from $2.00 to $7.00. On average, they predict the company's stock price to reach $4.50 in the next twelve months. This suggests a possible upside of 1,263.6% from the stock's current price.
View analysts price targets for PHGE or view top-rated stocks among Wall Street analysts.
How have PHGE shares performed in 2023?: BiomX's stock was trading at $0.1870 at the beginning of 2023. Since then, PHGE stock has increased by 76.5% and is now trading at $0.33.
View the best growth stocks for 2023 here.
When is BiomX's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our PHGE earnings forecast.
How were BiomX's earnings last quarter?: BiomX Inc. (NYSEMKT:PHGE) issued its quarterly earnings results on Monday, May, 15th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.02.

What other stocks do shareholders of BiomX own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BiomX investors own include Abiomed (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), ARCA biopharma (ABIO), AbbVie (ABBV) and AudioEye (AEYE).
What is BiomX's stock symbol?: BiomX trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "PHGE."
How do I buy shares of BiomX?: Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is BiomX's stock price today?: One share of PHGE stock can currently be purchased for approximately $0.33.
How much money does BiomX make?: BiomX (NYSEMKT:PHGE) has a market capitalization of $15.17 million. The company earns $-28,320,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.
How can I contact BiomX?: BiomX's mailing address is 7 PINHAS SAPIR ST. FLOOR 2, NESS ZIONA L3, 7414002. The official website for the company is www.biomx.com. The company can be reached via phone at 972 7 23942377 or via email at noelk@biomx.com.

This page (NYSEMKT:PHGE) was last updated on 9/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BiomX (PHGE) Stock Forecast, Price & News

BiomX MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

Company Ownership

Earnings and Valuation

About BiomX (NYSEMKT:PHGE) Stock

PHGE Price History

PHGE Stock News Headlines

PHGE Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

PHGE Stock - Frequently Asked Questions

Overall MarketRank^™